The presence of autoantibodies in COVID-19, specifically ANA and RF, has been correlated with CRP levels [59] and shown to be higher overall than in uninfected controls, with targets involving immunomodulatory proteins including cytokines, chemokines, complement factors, and cell surface proteins [60]. The gene discussed is BTG3; the disease is COVID-19.